Title: JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.
Journal: Clinical and translational medicine 20160101
Title: Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.
Journal: Annals of the rheumatic diseases 20120501
Title: Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.
Journal: Bioorganic & medicinal chemistry letters 20120201
Title: Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Journal: American journal of nephrology 20110101
Title: Plantevin Krenitsky V, et al. Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1433-8.
Title: Gan LT, et al. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. J Hepatol. 2014 Dec;61(6):1376-84.
Title: Reich N, et al. Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis. Ann Rheum Dis. 2012 May;71(5):737-45.
Title: Tavernier SJ, et al. Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival. Nat Cell Biol. 2017 Jun;19(6):698-710.
